Understanding model performance on this set of unseen diseases is an imperative step in developing a robust and clinically useful model that can be trusted in real world situations. In this work, we evaluated the DLS’s performance on 6 independent test sets consisting of different patient ...
and suppresses the action of glycoprotein 120 (gp120), a subunit of the HIV-1 glycoprotein 160 (gp160) envelope glycoprotein that facilitates HIV-1 attachment to host-cell receptors and other immune cells, which is the first step towards preventing HIV-1 virus infection [12]. According to Ko...